Bayer Schering Pharma AG Germany Owns Alka Seltzer

Bayer Schering Pharma Ag Germany Owns Alka Seltzer Which Was Launche

Bayer Schering Pharma AG, Germany owns Alka-Seltzer, which was launched in 1931 and was meant for relief of minor aches, pains, inflammation, fever, headache, heartburn, sour stomach, indigestion, and hangovers. Alka-Seltzer Plus was a spin-off of the original medicine, meant to relieve colds and flu. The company has recently introduced a new and improved Alka-Seltzer Plus, as described in this TV ad. The ad shows that Alka-Seltzer Plus can fight congestion, unlike NyQuil. Explain how Alka-Seltzer Plus has been quality and price-positioned in an existing market. In your opinion, has Bayer positioned their product appropriately in the market for cold and flu symptoms relief products? Would you advise Bayer to use a skimming or a penetration pricing strategy? Explain your reasoning. How do you think Procter and Gamble, the company who produces Vicks NyQuil, would respond to the ad? Guided Response: In 300 words or more, please, provide your response to the above discussion question. If Bayer is currently making normal profits on most of the products in its product line, but is making pure profits on its new Alka-Seltzer Plus with decongestant, what should Bayer do to increase its profits? Respond substantively to at least two of your classmates’ postings. Substantive responses use theory, research, and experience or examples to support ideas and further the class knowledge on the discussion topic.

Paper For Above instruction

Introduction

The pharmaceutical industry is characterized by intense competition and rapid innovation, especially in over-the-counter (OTC) products aimed at cold and flu relief. Bayer Schering Pharma AG has a long-standing history with its flagship product Alka-Seltzer, initially launched in 1931. The company's latest iteration, Alka-Seltzer Plus, targets consumers seeking relief from congestion, cold, and flu symptoms. This paper explores how Bayer has positioned Alka-Seltzer Plus in the market, assessing its quality and price positioning, and evaluates the appropriateness of their marketing approach. Further, the discussion addresses optimal pricing strategies—skimming versus penetration—and considers potential competitive responses, notably from Procter & Gamble’s Vicks NyQuil. Lastly, we explore profit-maximization strategies for Bayer's product line, focusing on their high-profit Alka-Seltzer Plus formulation.

Market Positioning of Alka-Seltzer Plus

Bayer’s strategic positioning of Alka-Seltzer Plus is primarily centered on quality differentiation and targeted marketing. By promoting Alka-Seltzer Plus as an effective cold and flu remedy capable of fighting congestion, Bayer has differentiated the product from competitors such as NyQuil. NyQuil has historically emphasized its sedative and symptom-relief properties, often positioning itself as a nighttime remedy. Conversely, Bayer emphasizes rapid relief and multi-symptom coverage, including congestion relief, which appeals to consumers seeking quick, daytime symptom alleviation.

Price-wise, Bayer has positioned Alka-Seltzer Plus at a premium to standard OTC cold remedies, emphasizing its enhanced efficacy and the inclusion of added decongestants. This positioning aligns with the perception of quality associated with Bayer's longstanding reputation in pharmaceuticals. The premium price underscores the product’s differentiated value proposition, targeting consumers willing to pay more for effective relief, especially those with persistent symptoms requiring rapid response.

Market Appropriateness and Pricing Strategy

From a market perspective, Bayer’s positioning appears appropriate given demographic trends and consumer preferences favoring fast-acting, reliable remedies. The emphasis on congestion relief caters to a broad segment, especially during flu seasons when congestion is a prominent concern. Bayer’s approach of emphasizing quality and efficacy aligns with consumer expectations for OTC medications.

Regarding pricing strategy, employing a skimming approach could be advantageous. Since Alka-Seltzer Plus offers a differentiated benefit, Bayer can initially set higher prices to recover development costs and capitalize on early adopters who value innovation. Over time, as competition increases or new entrants enter the market, Bayer could consider lowering prices to penetrate wider market segments, balancing profitability with market share expansion.

Alternatively, a penetration pricing strategy might be less suitable at this stage because it could undervalue the product’s perceived quality and diminish its premium image. Given the premium positioning and perceived added value, skimming allows Bayer to maximize profits initially while maintaining a perception of exclusivity and efficacy.

Competitive Response and Strategic Considerations

Procter & Gamble’s Vicks NyQuil has traditionally projected an image of strong nighttime symptom relief, including sedative properties. The new TV ad positioning Alka-Seltzer Plus as a congestion-fighting remedy could provoke a strategic response from P&G. They might emphasize NyQuil’s sedative efficacy or introduce their own formulations targeting congestion or daytime relief to maintain competitive advantage.

P&G could also respond by emphasizing their brand recognition and trust among consumers, further differentiating their product through new formulations or advertising claims. They might escalate marketing efforts or modify their messaging to counter Bayer’s emphasis on congestion relief, ensuring NyQuil remains top-of-mind for consumers seeking comprehensive cold and flu relief.

Maximizing Bayer’s Profits

Bayer’s current situation of earning pure profits on the new Alka-Seltzer Plus with decongestant suggests the possibility of maximizing revenue through price differentiation and targeted marketing. They could implement a value-based pricing model, focusing on loyal customer segments who perceive clear benefits from the high-profit formulation.

Furthermore, Bayer should consider expanding promotional efforts for this high-margin product, such as bundling with complementary items or increasing direct-to-consumer advertising to boost demand. They might also explore tiered pricing based on geographic or demographic segmentation, ensuring that their most profitable markets are fully exploited.

Finally, Bayer could consider extending the high-profit formulation to new segments or regions where consumer demand for effective cold and flu remedies is high. Vertical integration, such as investing in supply chain efficiencies, could further increase profit margins while maintaining product quality.

Conclusion

Bayer’s strategic positioning of Alka-Seltzer Plus as a premium, effective remedy for cold and flu symptoms appears well-aligned with market expectations. The emphasis on quality and unique benefits such as congestion relief supports a premium pricing approach. While skimming strategies seem most appropriate initially, Bayer should remain flexible, responding swiftly to market changes and competitive actions. To maximize profitability, especially on their high-margin formulation, Bayer should leverage targeted marketing, geographic segmentation, and value-based pricing strategies. Overall, Bayer’s approach demonstrates an understanding of consumer needs and competitive dynamics, but continuous adaptation will be vital to sustaining long-term success.

References

• Armstrong, G., & Kotler, P. (2017). Principles of Marketing (17th ed.). Pearson.
• Chaloupka, F. J., & Wechsler, H. (2006). Price, policy, and youth smoking. Tobacco Control, 15(2), 118-122.
• Hollensen, S. (2015). Marketing Strategy: A Decision-Focused Approach (6th ed.). Pearson.
• Kapferer, J. N. (2012). The New Strategic Brand Management: Advanced Insights and Strategic Thinking. Kogan Page.
• McCarthy, E. J., & Perreault, W. D. (2014). Basic Marketing: A Managerial Approach. McGraw-Hill Education.
• Porter, M. E. (1985). Competitive Advantage. Free Press.
• Schrage, M. (2020). Pricing Strategies for Competitive Markets. Harvard Business Review, 98(3), 50-57.
• Smith, P. R., & Zook, Z. (2016). Marketing Communications: Integrating Offline and Online with Social Media. Kogan Page.
• Srinivasan, R., & Mason, C. (2015). Strategic Pricing in Consumer Goods: A Review of Empirical Literature. Journal of Marketing Analytics, 3(4), 250-258.
• Zeithaml, V. A., & Bitner, M. J. (2012). Services Marketing: Integrating Customer Focus Across the Firm. McGraw-Hill Education.